EDUCATION:<\/p>\n
1999-2006\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PhD in Pharmacy, Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, University of Medicine and Pharmacy \u201cIuliu Hatieganu\u201d Cluj-Napoca, Romania<\/p>\n
1989-1994\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 B.Sc in Chemistry and Physics, Faculty of Chemistry and Chemical Engineering, Babes-Bolyai University Cluj-Napoca, Romania<\/p>\n
RESEARCH EXPERIENCE:<\/p>\n
10.2007-present\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Senior researcher, at Functional Genomics and Experimental Pathology Department, The Oncology Institute \u201cProf. Dr. I. Chiricuta\u201d, Cluj-Napoca, Romania<\/p>\n
11.1996-10.2007\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Researcher at Experimental Pathology Department, The Oncology Institute \u201cProf. Dr. I.Chiricuta\u201d, Cluj-Napoca, Romania<\/p>\n
06.2003-05.2004\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PhD Marie-Curie fellow (QLGA-1999-50406) at Functional Genomics Department, Institute Gustave Roussy, Villejuif, France<\/p>\n
04.2002-07.2002\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Internship (World Bank Grant) at the Department of Radiosensitivity UPRES EA 27-10, Gustave Roussy Institute, Villejuif, France<\/p>\n
05.1994-10.1996\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Volunteer at Radiotherapy and Medical Oncology Department, The Oncology Institute \u201cProf. Dr. I.Chiricuta\u201d, Cluj-Napoca, Romania<\/p>\n
Volunteer at\u00a0\u00a0 Experimental Pathology Department, The Oncology Institute \u201cProf. Dr. I.Chiricuta\u201d, Cluj-Napoca, Romania<\/p>\n
INTERNATIONAL AND NATIONAL GRANTS (MANAGEMENT):<\/p>\n
2012-1015\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Project Director in national project -Analysis of microRNA biomarkers as predictive values for cervical cancer treatment, in relationship with environmental exposure to arsenic, phthalates and ETS (Cervicall-arsen-array no 96\/2012)<\/p>\n
2008-2011\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Project Director in national project – The identification of the transcriptomic molecular profiles in advanced stage cervical cancer using functional genomics studies (Cervixarray 42-160\/2008)<\/p>\n
2007-2010\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Project Director in national project – Identification trough microarray technology of non-invasive predictive tumoral biomarkers in prostate cancer (IDEI: ID_314\/2007)<\/p>\n
2007-2010\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Manager in national project – Molecular profile definition (transcriptomics) in prediction of clinical status in breast cancers resistant to antracyclines. Metastatic disease definition in relation to primary tumor (Breastomics 41-029\/2007)<\/p>\n
2004-2008\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Member in more than 10 national projects granted by Medical Academy of Science and Minister of Science and Research from Romania<\/p>\n
2003-2004<\/p>\n
SELECTION OF PUBLICATIONS IN GENOMICS AND CANCER RESEARCH:<\/p>\n
1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Virag P, Fischer-Fodor E, Perde-Schrepler M, Brie I, Tatomir C, Balacescu L, Berindan-Neagoe I, Victor B, Balacescu O. Oxaliplatin induces different cellular\u00a0 and molecular chemoresistance patterns in colorectal cancer cell lines of identical origins. BMC Genomics. 2013 Jul 16;14:480<\/p>\n
2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Chirila DN, Popp RA, Balacescu O, Turdeanu NA, Constantea NA, Pop TR, Vesa SC, Ciuce C. GST gene variants in synchronous colorectal cancers and synchronous association of colorectal cancers with other cancers. Chirurgia (Bucur). 2013 May-Jun;108(3):365-71<\/p>\n
3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Berindan-Neagoe I, Braicu C, Pileczki V, Cojocneanu Petric R, Miron N, Balacescu O, Iancu D, Ciuleanu T. 5-Fluorouracil potentiates the anti-cancer effect of oxaliplatin on Colo320 colorectal adenocarcinoma cells. J Gastrointestin Liver Dis. 2013 Mar;22(1):37-43<\/p>\n
4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Miron N, Susman S, Balacescu O, Buiga R, Berindan-Neagoe I, Cristea V, Balacescu L, Manolescu V, Ciuleanu TE. Novel cellular and molecular approaches to stratification and treatment of colorectal cancer. J Gastrointestin Liver Dis. 2012 Dec;21(4):413-21<\/p>\n
5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Berindan-Neagoe I, Braicu C, Tudoran O, Balacescu O, Irimie A. Early apoptosis signals induced by a low dose of epigallocatechin 3-gallate interfere with apoptotic and cell death pathways. J Nanosci Nanotechnol. 2012 Mar;12(3):2113-9<\/p>\n
6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Berindan-Neagoe I, Chiorean R, Braicu C, Florian IS, Leucuta D, Crisan D, Cocis A, Balacescu O, Irimie A. Quantitative mRNA expression of genes involved in angiogenesis, coagulation and inflammation in multiforme glioblastoma tumoral tissue versus peritumoral brain tissue: lack of correlation with clinical data. Eur Cytokine Netw. 2012 Jun;23(2):45-55<\/p>\n","protected":false},"excerpt":{"rendered":"
EDUCATION: 1999-2006\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PhD in Pharmacy, Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, University of Medicine and Pharmacy \u201cIuliu Hatieganu\u201d Cluj-Napoca, Romania 1989-1994\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 B.Sc in Chemistry and Physics, Faculty of Chemistry and Chemical Engineering, Babes-Bolyai University Cluj-Napoca, Romania RESEARCH … Continue reading